Supporting CoQ10 Supplement
Development From Research to Market

Executive Takeaways

1. Science-backed Ubiquinol supplement development requires technical expertise, clinical claims substantiation, stability-focused formulation design, and manufacturing feasibility.
2. Kaneka’s Research-to-Business approach helps reduce formulation risk through compatibility assessment, product testing, scale-up guidance, and documentation readiness.
3. Our validated ready-for-market delivery formats enable faster, more reliable commercialization of differentiated Kaneka Ubiquinol^® products across multiple dosage forms.

Developing a successful Ubiquinol supplement requires more than sourcing a high-quality ingredient. It demands scientific substantiation, formulation expertise, manufacturing precision, application of clinical research, and documentation readiness to ensure commercial viability.

At Kaneka Nutrients, we support supplement brand partners across the full development lifecycle, from early research evaluation through formulation design, scale-up, and market entry.

As the global pioneer in CoQ10 commercialization and the manufacturer of Kaneka Ubiquinol^®, the active antioxidant form of CoQ10, Kaneka combines decades of clinical and scientific research, proprietary fermentation-based manufacturing, and application expertise to support technically sound and commercially scalable product development.

Kaneka partners with science-driven supplement brands seeking clinically supported ingredients, strict quality standards, and differentiated product development pathways.

Our CoQ10 portfolio is supported by extensive clinical research and stability data, and in-depth evaluation of formulation impact across delivery systems. This scientific foundation enables structured collaboration with brand and manufacturing partners to translate research into viable supplement products.

In this blog, we outline Kaneka’s approach to product development, customized ready-for-market solutions, and validated delivery formats supported through our Research-to-Business framework.

Effective supplement formulation begins with a strong scientific and technical foundation. Kaneka provides research-informed guidance to support brands developing CoQ10 products across multiple health areas. That guidance is informed by scientific discipline, decades of positive consumer and commercial experience, and proprietary knowledge of the CoQ10 (ubiquinone and ubiquinol) molecular forms.

Kaneka Ubiquinol^® is supported by clinical and scientific research evaluating its role in mitochondrial energy production and antioxidant function. Our technical teams work with partners to translate this body of evidence into practical formulation strategies aligned with defined supplement applications. This science-backed foundation provides brands with a higher level of ingredient reliability and substantiation, supporting responsible product development and market placement.

Ubiquinol-based formulations are appropriate across a range of supplement applications, including:

• Healthy aging
• Cardiovascular health
• Mitochondrial health
• Preconception wellness
• Menopausal well-being
• Women’s health
• Sports nutrition

Within these categories, formulation considerations may include aligning supplementation levels with clinical evidence, optimizing the formulation to enhance absorption, and maintaining product stability throughout its shelf life.

Different supplement categories have distinct technical requirements. For example:

• Lipid-based systems may be preferred for enhanced solubility in certain formats.
• Multi-ingredient formulations require evaluation of nutrient interactions and oxidative stability.
• Sports or active lifestyle applications may require format flexibility and scalable manufacturing efficiency.

Our expertise in lipid-soluble molecules and ingredient interaction dynamics supports formulation stability and performance across various dosage forms. Additionally, our application expertise supports the development of formulations customized to your desired category while ensuring stability and ingredient integrity.

Kaneka works directly with brand R&D teams and contract manufacturers to assess feasibility early in the product development cycle. This includes:

• Format assessment across multiple delivery systems, including softgels, hard-shell capsules, fast-dissolving tablets, powders, gummies, sachets, and stick packs
• Stability modeling and test protocol guidance
• Processing considerations for oxidation-sensitive materials
• Scale-up planning to support commercial production

Our collaborative approach lowers reformulation risk, supports the transition from concept to commercialization, and helps ensure that finished formulations are manufactured to maintain labeled potency and quality specifications throughout their shelf life.

Research-driven product development enables targeted category positioning and formulation differentiation. At the same time, product development must account for:

• Stability concerns
• Matrix compatibility and optimization
• Manufacturing process limitations
• Validation timelines

Kaneka’s technical services team supports partners in managing innovation while ensuring manufacturability and documentation readiness.

For brands seeking differentiated product concepts, Kaneka supports adaptable ready-for-market development pathways designed to meet specific formulation objectives. Kaneka’s Research-to-Business team supports adaptable development pathways to accommodate custom formulation and format requirements.

Customized solutions may include:

• Kaneka Ubiquinol^® combined with complementary nutrients
• Health category and application-specific dosage configurations
• Delivery system optimization throughout formats such as softgels, liquid-filled capsules, cap-within-cap systems, powders, gummies, fast-dissolving tablets or lozenges, and stick packs
• Stability-adjusted formulations for complex matrices

Each customized approach is evaluated for ingredient compatibility, oxidative stability, scalability, and conformance with quality standards and established specifications.

Kaneka’s vertically integrated CoQ10 production site—from fermentation to finished ingredient—ensures control over purity, consistency, and supply reliability. Custom development programs are designed with commercial scalability in mind, supporting development from pilot batch to full production.

Customized ready-for-market solutions enable brands to build proprietary differentiation and address defined market opportunities. Kaneka supports partners across development stages to advance innovation while ensuring commercial feasibility and product integrity.

To accelerate commercialization, Kaneka offers structured, ready-for-market formats supported by our Research-to-Business framework.

Ready-for-market formats are validated, finished supplement formulations developed to support efficient manufacturing while ensuring ingredient stability. These solutions are developed and implemented in collaboration with brand partners.

Available formats include:

• Softgels and their lipid-based matrix
• Two-piece hard-shell capsules
• Powder blends
• Gummy applications
• Single-serve stick packs
• Cap-within-cap systems designed to separate incompatible ingredients within a single dosage unit
• Powdered stabilized Ubiquinol for compressible tablet applications
• Fast-dissolve tablets, lozenges, and portable sachet formats

These frameworks are designed to reduce formulation uncertainty and shorten development timelines while maintaining Ubiquinol integrity.

Ready-for-market solutions support scale-up and offer supply continuity, as well as readiness for commercial launch aligned with U.S. quality standards and regulatory criteria. With predefined formulation parameters, partners can reduce technical risk and accelerate commercialization.

In addition to formulation design, Kaneka’s Research-to-Business integrated services provide:

• Scientific research evaluation
• Manufacturing expertise
• Formulation expertise
• Quality assurance systems
• Stability testing data and protocol support
• Product specifications and Certificates of Analysis
• Claims substantiation support
• Regulatory documentation guidance

Our team works with supplement manufacturers to support format selection, ingredient compatibility assessment, formulation optimization, and technical testing—helping ensure the dosage form corresponds to customer goals.

Kaneka Ubiquinol^® is produced under current Good Manufacturing Practices (cGMP) and is self-affirmed Generally Recognized as Safe (GRAS) for conventional food use, and has a successful New Dietary Ingredient (NDI) notification filed with the FDA, supporting partner confidence in quality and regulatory readiness.

In this way, we support partners to move from validated research to market-ready products with technical transparency and documentation readiness.

Ready-for-market formats offer:

• Reduced development timelines
• Proven stability
• Structured technical documentation
• Lower formulation risk
• Speed to implementation into product category

These formats provide efficiency and reliability for brands prioritizing speed to market.

From early research evaluation and category-specific formulation guidance to customized development and validated ready-for-market formats, Kaneka Nutrients supports supplement brands throughout the entire Ubiquinol product lifecycle.

Through its proprietary fermentation manufacturing, broad clinical research foundation, and structured Research-to-Business framework, Kaneka enables partners to translate scientific insight into stable, scalable, and commercially viable supplement products.

Contact us to explore how Kaneka Nutrients can support your next Ubiquinol supplement initiative—from formulation strategy to market readiness.

Sid brings decades of experience in nutrition product development, spanning quality, clinical research, raw materials, and CMO partnerships. He specializes in Ubiquinol and probiotics, advancing innovation in heart and gut health.